These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9596689)

  • 1. Erythropoietin prevents the development of interleukin-12-induced anemia and thrombocytopenia but does not decrease its antitumor activity in mice.
    Gołab J; Zagozdzon R; Stokłosa T; Jakóbisiak M; Pojda Z; Machaj E
    Blood; 1998 Jun; 91(11):4387-8. PubMed ID: 9596689
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of chemotherapy-induced anemia and thrombocytopenia by constant administration of stem cell factor.
    Bartucci M; Dattilo R; Martinetti D; Todaro M; Zapparelli G; Di Virgilio A; Biffoni M; De Maria R; Zeuner A
    Clin Cancer Res; 2011 Oct; 17(19):6185-91. PubMed ID: 21868766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin and platelet production.
    Erslev AJ
    Blood; 1992 Dec; 80(12):3251. PubMed ID: 1296664
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preventing and treating hematologic complications of anticancer chemotherapy: update on hematopoietic growth factors].
    Spaëth D; Geoffrois L; Conroy T
    Bull Cancer; 2000 Jan; 87(1):93-6. PubMed ID: 10673637
    [No Abstract]   [Full Text] [Related]  

  • 5. Large, chronic doses of erythropoietin cause thrombocytopenia in mice.
    McDonald TP; Clift RE; Cottrell MB
    Blood; 1992 Jul; 80(2):352-8. PubMed ID: 1627797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy-induced anemia.
    Gołab J; Olszewska D; Mróz P; Kozar K; Kamiński R; Jalili A; Jakóbisiak M
    Clin Cancer Res; 2002 May; 8(5):1265-70. PubMed ID: 12006547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of conagenin on thrombocytopenia induced by antitumor agents in mice.
    Kawatsu M; Yamashita T; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1994 Oct; 47(10):1123-9. PubMed ID: 7961162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice.
    Kalechman Y; Rushkin G; Nerubay J; Albeck M; Sredni B
    Exp Hematol; 1995 Dec; 23(13):1358-66. PubMed ID: 7498364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human interleukin-11 improved carboplatin-induced thrombocytopenia without affecting antitumor activities in mice bearing Lewis lung carcinoma cells.
    Saitoh M; Taguchi K; Momose K; Suga K; Yamazaki N; Ono C; Suzuki T; Takeuchi O; Yasuda S; Miyata K
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):161-6. PubMed ID: 11862431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TITAN: modifying an innovative American program for use with a European audience.
    Ahlberg K; Dielenseger P; Dolan S; Foubert J; Munoz M; Ouwerkerk J; Uhlenhopp M; Wujcik D; ;
    J Support Oncol; 2005; 3(6 Suppl 4):34-5. PubMed ID: 16355561
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementation of cytokines to optimize cancer treatment outcomes.
    Smith JA
    J Support Oncol; 2007 Apr; 5(4 Suppl 2):89-91. PubMed ID: 17550058
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclophosphamide regimens in rhesus monkey with and without marrow infusion.
    Storb R; Buckner CD; Dillingham LA; Thomas ED
    Cancer Res; 1970 Aug; 30(8):2195-203. PubMed ID: 4990004
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of combined treatment with interleukin 1 and erythropoietin or GM-CSF and erythropoietin on the regeneration of hemopoiesis in the dog after total body irradiation--a preliminary report.
    Selig C; Nothdurft W; Kreja L; Fliedner TM
    Behring Inst Mitt; 1991 Dec; (90):86-92. PubMed ID: 1801695
    [No Abstract]   [Full Text] [Related]  

  • 14. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment.
    Harrison J; Kappas A; Levere RD; Lutton JD; Chertkov JL; Jiang S; Abraham NG
    Blood; 1993 Dec; 82(12):3574-9. PubMed ID: 8260696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007.
    Wu Y; Aravind S; Ranganathan G; Martin A; Nalysnyk L
    Clin Ther; 2009; 31 Pt 2():2416-32. PubMed ID: 20110050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies to ameliorate toxicity of carboplatin.
    ten Bokkel Huinink WW; Dercksen MW; van Tinteren H
    Semin Oncol; 1994 Apr; 21(2 Suppl 2):27-33; quiz 34, 58. PubMed ID: 8202718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential use of recombinant human interleukin-6 in clinical oncology.
    Veldhuis GJ; Willemse PH; Mulder NH; Limburg PC; De Vries EG
    Leuk Lymphoma; 1996 Feb; 20(5-6):373-9. PubMed ID: 8833392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic model for chemotherapy-induced anemia in rats.
    Woo S; Krzyzanski W; Jusko WJ
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):123-33. PubMed ID: 17891399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of hematologic toxicity of carboplatin by creatinine clearance rate.
    Taguchi J; Saijo N; Miura K; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Sakurai M; Minato K; Fujiwara Y
    Jpn J Cancer Res; 1987 Sep; 78(9):977-82. PubMed ID: 3117753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprotective effects of KF41399, a derivative of carbazole compounds, on nimustine-induced thrombocytopenia.
    Shiotsu Y; Yamashita K; Kanai F; Ikuina Y; Murakata C; Teramura M; Mizoguchi H; Tamaoki T; Akinaga S
    Blood; 2000 Jun; 95(12):3771-80. PubMed ID: 10845909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.